Initial results of a new access device for hemodialysis: Technical Note

Levin, Nathan W.; Yang, Paul M.; Hatch, David A.; Dubrow, Alan; Caraiani, Nicolae S.; Ing, Todd S.; Gandhi, Vasant C.; Alto, Althea; Davila, Sylvia M.; Prosl, Frank R.; Polaschegg, Hans D.; Megerman, Joseph

doi:10.1046/j.1523-1755.1998.00128.x

Cited by 29 publications

(17 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Two devices were explanted because of thrombotic material around catheter tips, in order to rule out infection [6]. In two further patients stripping of fibrin sheaths was performed to recanalize the catheters [10].…”

Section: Discussionmentioning

confidence: 99%

Implantation of a New Access Device for Hemodialysis (Dialock): Initial Experience in 5 Patients

Schmitz‐Rode¹,

Bucker²,

Tacke³

et al. 2001

Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Implantation of a New Access Device for Hemodialysis (Dialock): Initial Experience in 5 Patients

Schmitz‐Rode¹,

Bucker²,

Tacke³

et al. 2001

Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr

View full text Add to dashboard Cite

“…In the next years the use of new access devices for HD [22] will make us reconsider the problem under new points of view.…”

Section: Discussionmentioning

confidence: 99%

Successful Use of Central Venous Catheter as Permanent Hemodialysis Access: 84-Month Follow-Up in Lucania

Iorio¹,

Lopez

Procida³

et al. 2000

Blood Purif

View full text Add to dashboard Cite

Cuffed tunneled venous access catheters are commonly used for temporary and permanent access in hemodialysis (HD) patients. These catheters serve an essential role in providing permanent access in subjects in whom all other access options have been exhausted. The predominant complications are catheter thrombosis, catheter fibrin sheating and infection. The aim of this study was to evaluate long-term survival and complications of permanent venous catheters (PVC) placed for the purpose of HD during the period from January 1992 to December 1998, at the Dialysis Units of Lucania (a southern Italian region). A total of 98 PVC were placed in 88 patients during this period. The catheters used were of three types: (a) 72 VasCath Soft Cell catheters (Bard Instrument Company, Toronto, Ont., Canada); (b) 22 PermCath catheters (Quinton Instrument Company, Seattle, Wash., USA), and (c) 4 Tesio catheters (Bellco SpA, Mirandola, Italy). Survival curves of catheters were calculated using the Kaplan-Meier product-limit estimator. The patient survival was 60% at the 78th month. Actually, 52 patients (27 males, 25 females) are still alive: 15 (26.9%) of these patients have diabetes mellitus and 1 has been transplanted. The actuarial survival rate of PVC was 89% in the whole population studied and 82% in subjects alive after 84 months. Twenty-five patients (28.4%) had PVC as the first reliable vascular access. Long-term complications occurred 27 times (1 episode every 44.81 month/patient) as: breakage (3.1%); thrombosis (10.2%); displacement (2.0%); subcutaneous tunnel bleeding (3.1%); inadequate blood flow (7.1%), and infection (10.2%). In conclusion, our data confirm that PVC might represent an effective long-term blood access route for HD. Again, PVC are getting the access of choice for selected patients (i.e., older subjects with cardiovascular diseases and cancer patients) and are enjoying a dramatic increase in use for subjects who are terrified of repetitive venopuncture.

show abstract

“…The initial Dialock cannulation was not delayed in the majority of patients in whom the device could be readily accessed. Dialock was successfully used to treat 23 ESRD patients on a regular dialysis schedule over a prolonged period of time (3-18 months) (27). More than 90% of patients reported being comfortable and satisfied with the device after the second week of use.…”

Section: Discussionmentioning

confidence: 99%

“…This study reports additional results of the international pilot trial clinical trial with the Dialock hemodialysis access device (21).…”

mentioning

confidence: 98%

Dialock: Pilot Trial of a New Vascular Port Access Device for Hemodialysis

Canaud¹,

Levin

Ing

et al. 1999

Seminars in Dialysis

Self Cite

View full text Add to dashboard Cite

Initial results of a new access device for hemodialysis: Technical Note

Abstract: The device represents a positive improvement in the area of HD access.

Cited by 29 publications

References 15 publications

Implantation of a New Access Device for Hemodialysis (Dialock): Initial Experience in 5 Patients

Implantation of a New Access Device for Hemodialysis (Dialock): Initial Experience in 5 Patients

Successful Use of Central Venous Catheter as Permanent Hemodialysis Access: 84-Month Follow-Up in Lucania

Dialock: Pilot Trial of a New Vascular Port Access Device for Hemodialysis

Contact Info

Product

Resources

About